French court rules against Sanofi in landmark Depakine case
Sanofi has faced a slew of allegations over the last several years that its epilepsy drug Depakine causes birth defects when taken during pregnancy. Last …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
